SCHEMBL28808495

SCHEMBL28808495

CCC(=O)Oc1c(NC(=O)C(=O)OC)cccc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.42
TP53 P04637 1/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ALDH1A1 P00352 3/20 0.41
GAA P10253 1/20 0.41
LMNA P02545 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.39
MAPK1 P28482 1/20 0.39
GPR35 Q9HC97 1/20 0.39
POLB P06746 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28820760 0.86 PKM (0.47) KMT2ATP53MEN1MAPTNPSR1
SCHEMBL28997780 0.85 ALDH1A1 (0.38) KMT2AMEN1MAPTNPSR1ALDH1A1
SCHEMBL29019476 0.81 KMT2A (0.40) KMT2ATP53MEN1MAPTALDH1A1
SCHEMBL4819312 0.80 POLB (0.43) KMT2AMEN1MAPTALDH1A1GAA
SCHEMBL28820775 0.77 BCL9 (0.46) KMT2ATP53MEN1MAPTNPSR1
SCHEMBL258593 0.76 GPR35 (0.47) KMT2AMEN1MAPTALDH1A1L3MBTL1
SCHEMBL7388321 0.75 ACHE (0.42) KMT2ATP53MAPTALDH1A1LMNA
SCHEMBL28809383 0.74 MAPT (0.40) KMT2AMEN1MAPTALDH1A1GAA
SCHEMBL29019450 0.74 EPHX2 (0.46) KMT2ATP53MEN1ALDH1A1GAA
SCHEMBL6063920 0.73 ALDH1A1 (0.53) KMT2AMEN1MAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728914-B Dioxopiperazine derivative, preparation method thereof and application thereof in medicines 深圳信立泰药业股份有限公司 2023-05-12 CN disclosed
CN-114728914-A Dioxopiperazine derivative, preparation method and medical application thereof 深圳信立泰药业股份有限公司 2022-07-08 CN disclosed